Peripheral Artery Disease

LAS VEGAS — A repuncturable vascular mimetic peripheral stent system was safe and effective at 2 years in patients with common femoral artery disease, according to new data from the VMI-CFA study.

SAN FRANCISCO — Analyses continue to show a long-term mortality risk associated with paclitaxel-coated devices in patients with peripheral artery disease, but investigators are no closer to determining a cause, according to members of a panel convened at TCT 2019.

PARIS — Patients with peripheral artery disease who maintained use of high-intensity statin therapy had significantly lower mortality than those who reduced the intensity of statin treatment or stopped taking statins, researchers reported.

In a retrospective analysis of Japanese patients with peripheral artery disease treated with paclitaxel-coated devices or other devices, paclitaxel-coated devices were not associated with elevated mortality risk at 5 years.

Exposure to anti-TNF reduced the risk for acute arterial events in patients with inflammatory bowel disease, according to results of a large, nationwide study in France.

Among patients with peripheral artery disease who underwent a surgical or endovascular intervention, statin use after the procedure was associated with better odds of survival and limb salvage, researchers reported.